MedPath

Ferring Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ferringusa.com

A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2010-10-14
Last Posted Date
2025-04-13
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
110
Registration Number
NCT01220869
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

🇨🇳

Chi-Mei Foundation Hospital, Tainan, Taiwan

🇨🇳

Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

and more 7 locations

Compliance and Efficacy in the Use of PICOPREP®

Completed
Conditions
Bowel Cleanliness
First Posted Date
2010-10-14
Last Posted Date
2012-10-08
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
2165
Registration Number
NCT01220453
Locations
🇩🇪

Investigational site, Singen, Germany

🇩🇪

Investigational Site, Wriezen, Germany

🇩🇪

Private Practice, Bietigheim-Bissingen, Germany

A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer

Completed
Conditions
Prostate Cancer
First Posted Date
2010-10-06
Last Posted Date
2015-08-19
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
274
Registration Number
NCT01215526
Locations
🇳🇱

Flevoziekenhuis, Almere, Netherlands

🇳🇱

Bovenij Ziekenhuis, Amsterdam, Netherlands

🇳🇱

Wilhelminaziekenhuis, Assen, Netherlands

and more 42 locations

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2010-10-06
Last Posted Date
2013-05-22
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
127
Registration Number
NCT01215513
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

🇰🇷

Kyoungbuk National University Hospital, Daegu, Korea, Republic of

🇰🇷

Yonsei University Health System Gangnam Sevrance, Seoul, Eonguro, Gangnam-gu, Korea, Republic of

and more 8 locations

A Study of Minirin Melt in Patients With Nocturia

Completed
Conditions
Nocturia
First Posted Date
2010-09-30
Last Posted Date
2014-01-06
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
2187
Registration Number
NCT01212224
Locations
🇨🇿

Nemocnice Rudolfa a Stefanie, Benešov, Czech Republic

🇨🇿

Health centre Brno, Brno, Czech Republic

🇨🇿

Private ambulance Uro-Clinic, s.r.o., Brno, Czech Republic

and more 65 locations

Post Marketing Surveillance of MENOPUR

Completed
Conditions
Infertility
First Posted Date
2010-09-15
Last Posted Date
2014-02-21
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
2501
Registration Number
NCT01202123
Locations
🇰🇷

Daejeon Maria, Daejeon, Korea, Republic of

🇰🇷

Ilsan Maria Hospital, Ilsan, Gyeonggi Province, Korea, Republic of

🇰🇷

Songnae Maria Hospital, Seoul, Korea, Republic of

and more 16 locations

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding

Phase 4
Completed
Conditions
Menorrhagia
Interventions
First Posted Date
2010-08-27
Last Posted Date
2012-07-16
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
20
Registration Number
NCT01190150
Locations
🇺🇸

West Coast Clinical Trials, Cypress, California, United States

Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction

Phase 4
Terminated
Conditions
Vaginal Delivery
Cesarean Section
Interventions
First Posted Date
2010-08-27
Last Posted Date
2012-08-23
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
170
Registration Number
NCT01190163
Locations
🇧🇷

Hospital Maternidade Leonor Mendes de Barros, São Paulo, Brazil

🇧🇷

Hospital M Boi Mirim, São Paulo, Brazil

🇧🇷

Hospital Municipal Universitário - Faculdade de Medicina do ABC, São Bernardo, São Paulo, Brazil

and more 1 locations

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo

Phase 2
Completed
Conditions
Nocturia
Interventions
Drug: Placebo
First Posted Date
2010-08-19
Last Posted Date
2012-05-25
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
116
Registration Number
NCT01184859
Locations
🇯🇵

National Center for Geriatrics and Gerontology, Obu, Aichi, Japan

🇯🇵

Jyusendo General Hospital, Koriyama, Fukushima, Japan

🇯🇵

Kawahara Hinyoukika, Kagoshima, Japan

and more 33 locations

Quality of Life With TESTIM®

Completed
Conditions
Hypogonadism
First Posted Date
2010-06-22
Last Posted Date
2011-12-22
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
157
Registration Number
NCT01148433
Locations
🇩🇪

Investigational Site, Helene-Weigel-Platz 10, Berlin, Germany

🇩🇪

Investigational Site, Königin-Elisabeth-Straße 1, Berlin, Germany

🇩🇪

Investigational Site, Wolfsburg, Germany

and more 19 locations
© Copyright 2025. All Rights Reserved by MedPath